Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jan;68(1):31-42.
doi: 10.1007/s10840-022-01218-9. Epub 2022 Apr 23.

Impact of right ventricular pacing site on the subcutaneous ICD sensing-a step towards personalised device therapy?

Affiliations

Impact of right ventricular pacing site on the subcutaneous ICD sensing-a step towards personalised device therapy?

Mohamed ElRefai et al. J Interv Card Electrophysiol. 2025 Jan.

Abstract

Background: Patients with an existing subcutaneous implantable cardiac defibrillator (S-ICD) may develop a pacing indication. When transvenous pacing is not feasible, combining an S-ICD and a leadless pacemaker (LP) can be a reasonable option. There are reports of concomitant use of both devices. However, the effect of pacing on the S-ICD sensing is not well studied. We hypothesise that pacing changes R and T-wave amplitudes, causing changes in R:T ratios as perceived by a S-ICD, increasing the risk for T wave oversensing (TWO) during paced rhythm with a subsequent risk of inappropriate shocks.

Methods: This is a prospective study in patients undergoing electrophysiological studies. Participants were fitted with a Holter®, and the leads were placed to correspond to the vectors of an S-ICD. The right ventricle was paced at four positions for 10 beats each at 8 mA/2 ms. The Holter® traces were analysed, using two-way analysis of variance (ANOVA) to assess the effect of pacing on the R:T ratio.

Results: Forty-seven patients (age 56.02 ± 16.02, 72% male) were enrolled (81% structurally normal heart, 15% dilated cardiomyopathy, 2% ischaemic cardiomyopathy, and 2% adult congenital heart disease). Age, sex, and aetiology had no effect on the R:T ratio. Pacing caused significant changes in the R:T ratio. There was no significant difference in the R:T ratios between the pacing sites (p < 0.001).

Conclusions: Pacing alters the R:T ratio significantly in most patients, theoretically increasing the risk for TWO and inappropriate shocks. Tailored programming for both devices is important for concomitant use of LPs and S-ICDs.

Keywords: Cardiac implantable devices; Leadless pacemakers; Personalised medicine; Subcutaneous implantable cardiac defibrillators.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethics approval: The study was performed with ethical approval from Health Research Authority (HRA)—REC (20/NW/0366)—and was also granted local research and development (RHMCAR0528) approval. Consent to participate: All patients gave informed written consent prior to recruitment in the study. Conflict of interest: Dr. Mohamed ElRefai is receiving unrestricted grant from Boston Scientific. Dr. Paul Roberts receives consultancy fees from Boston Scientific and Medtronic. Prof. John Morgan is a senior medical director at Boston Scientific. Other authors have no conflicts of interest to declare.

Figures

Fig. 1
Fig. 1
Showing the typical S-ICD vectors on the left and on the right, the Holter® surface ECG positions. 1 = 1 cm infero-lateral to the xiphisternum, 2 = 14 cm superior to position 1, 3 = 5th intercostal space, parasternal position, 4 = 6th intercostal space left mid axillary line, 6 = Adjacent to 2, 7 = Adjacent to 4, Holter Channel A records between points 1 and 4 = surrogate of S-ICD primary vector, Holter Channel B records between points 2 and 3 = surrogate of S-ICD alternate vector, Holter Channel C records between points 6 and 7 = surrogate of S-ICD secondary vector, 5 = 5th intercostal space right mid clavicular line = neutral electrode, Image prior to annotation © Boston Scientific Corporation or its affiliates
Fig. 2
Fig. 2
Fluoroscopic images in the left anterior oblique (top row) and right anterior oblique (bottom row) views showing the pacing catheter placed at four different sites in the right ventricle corresponding to the potential implantation sites for the leadless pacemaker
Fig. 3
Fig. 3
Boxplot comparing between different pacing sites and the “no pacing” group. Significant decrease was noticed in the R:T ratio when pacing in any of the selected sites. Multiple outliers were detected in all the pacing sites with nearly isoelectric T waves. Vectors A, B, and C correspond to Primary, alternate, and secondary vectors of an S-ICD, respectively
Fig. 4
Fig. 4
An example of the effect of pacing as well as changing the pacing site on the morphology of the Holter traces corresponding to the S-ICD vectors. A, B, and C correspond to primary, alternate, and secondary vectors respectively

References

    1. Randles DA, Hawkins NM, Shaw M, Patwala AY, Pettit SJ, Wright DJ. How many patients fulfil the surface electrocardiogram criteria for subcutaneous implantable cardioverter-defibrillator implantation? EP Europace. 2014;16(7):1015–21. 10.1093/EUROPACE/EUT370. - PubMed
    1. Olde Nordkamp LRA, Warnaars JLF, Kooiman KM, et al. Which patients are not suitable for a subcutaneous ICD: incidence and predictors of failed QRS-T-wave morphology screening. J Cardiovasc Electrophysiol. 2014;25(5):494–9. 10.1111/JCE.12343. - PubMed
    1. Hauser RG, Hayes DL, Kallinen LM, et al. Clinical experience with pacemaker pulse generators and transvenous leads: an 8-year prospective multicenter study. Heart Rhythm. 2007;4(2):154–60. 10.1016/J.HRTHM.2006.10.009. - PubMed
    1. Kirkfeldt RE, Johansen JB, Nohr EA, Jorgensen OD, Nielsen JC. Complications after cardiac implantable electronic device implantations: an analysis of a complete, nationwide cohort in Denmark. Eur Heart J. 2014;35(18):1186–94. 10.1093/EURHEARTJ/EHT511. - PMC - PubMed
    1. Udo EO, Zuithoff NPA, van Hemel NM, et al. Incidence and predictors of short- and long-term complications in pacemaker therapy: the FOLLOWPACE study. Heart Rhythm. 2012;9(5):728–35. 10.1016/J.HRTHM.2011.12.014. - PubMed

LinkOut - more resources